Literature DB >> 17392447

Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit.

Hamid Jalal1, David F Bibby, Julie Bennett, Rebecca E Sampson, Nicola S Brink, Stephen MacKinnon, Richard S Tedder, Katherine N Ward.   

Abstract

A large simultaneous outbreak of respiratory syncytial virus (RSV) and parainfluenza type 3 (PIV-3) infections occurred on an adult hematology unit. Implementation of enhanced infection control was complicated by cocirculation of the two different viruses, with prolonged viral shedding from infected patients, and placed great pressure on health care staff; of 27 infected hematopoietic stem cell transplant patients, 9 died, and the unit was closed for 2 months. Retrospective molecular investigation of the virus strains involved in the outbreak was performed by analyzing part of the fusion gene of PIV-3 and part of the glycoprotein gene of RSV. Reverse transcription-PCR on nasopharyngeal aspirates from patients infected before and during the simultaneous outbreak generated amplicons for sequence analysis. A single strain of RSV and a single strain of PIV-3 had spread from person to person within the unit; 7 patients were infected with RSV, 22 were infected with PIV-3, and 4 were infected with both viruses. The PIV-3 outbreak had started at the beginning of August 3 months before the RSV outbreak; it had arisen when PIV-3 was introduced from the community by a patient and passed to another patient, who became chronically infected with the identical strain and, in spite of being nursed in isolation, was most likely the source from which widespread infection occurred in November. Had these early cases been linked to a common PIV-3 strain at the time of diagnosis, enhanced infection control precautions might have prevented the eventual extensive spread of PIV-3, making it much easier to deal with the later RSV outbreak.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392447      PMCID: PMC1933051          DOI: 10.1128/JCM.01912-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults.

Authors:  B L Jones; S Clark; E T Curran; S McNamee; G Horne; B Thakker; J Hood
Journal:  J Hosp Infect       Date:  2000-01       Impact factor: 3.926

2.  An outbreak of respiratory syncytial virus in a bone marrow transplant center.

Authors:  R D Harrington; T M Hooton; R C Hackman; G A Storch; B Osborne; C A Gleaves; A Benson; J D Meyers
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

3.  Survival and disinfection of parainfluenza viruses on environmental surfaces.

Authors:  M T Brady; J Evans; J Cuartas
Journal:  Am J Infect Control       Date:  1990-02       Impact factor: 2.918

4.  Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983.

Authors:  K L van Wyke Coelingh; C C Winter; B R Murphy
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

5.  Molecular epidemiology of outbreak of respiratory syncytial virus within bone marrow transplantation unit.

Authors:  G S Taylor; I B Vipond; E O Caul
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites.

Authors:  K V Coelingh; C C Winter
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

Authors:  K G Nicholson
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

8.  Parainfluenza virus respiratory infection after bone marrow transplantation.

Authors:  C H Wendt; D J Weisdorf; M C Jordan; H H Balfour; M I Hertz
Journal:  N Engl J Med       Date:  1992-04-02       Impact factor: 91.245

9.  Evolution of the fusion protein gene of human parainfluenza virus 3.

Authors:  K Prinoski; M J Côté; C Y Kang; K Dimock
Journal:  Virus Res       Date:  1992-01       Impact factor: 3.303

10.  Parainfluenza virus infection in adult bone marrow transplant recipients.

Authors:  E Whimbey; S E Vartivarian; R E Champlin; L S Elting; M Luna; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

View more
  36 in total

1.  Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.

Authors:  Niraj K Shil; Swechha M Pokharel; Amiya K Banerjee; Michael Hoffman; Santanu Bose
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

2.  Analysis of nucleotides 13-96 of the human parainfluenza virus type 3 antigenomic promoter reveals positive- and negative-acting replication elements.

Authors:  Jill R Gander; LeeAnne M Schwan; Michael A Hoffman
Journal:  Virology       Date:  2011-08-30       Impact factor: 3.616

Review 3.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

4.  Cross-immunity between strains explains the dynamical pattern of paramyxoviruses.

Authors:  Samit Bhattacharyya; Per H Gesteland; Kent Korgenski; Ottar N Bjørnstad; Frederick R Adler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

5.  The role of next generation sequencing in infection prevention in human parainfluenza virus 3 infections in immunocompromised patients.

Authors:  Atul Kothari; Mary J Burgess; Juan Carlos Rico Crescencio; Joshua L Kennedy; Jesse L Denson; Kurt C Schwalm; Ashley N Stoner; John C Kincaid; Faith E Davies; Darrell L Dinwiddie
Journal:  J Clin Virol       Date:  2017-05-12       Impact factor: 3.168

Review 6.  Progress in the development of human parainfluenza virus vaccines.

Authors:  Alexander C Schmidt; Anne Schaap-Nutt; Emmalene J Bartlett; Henrick Schomacker; Jim Boonyaratanakornkit; Ruth A Karron; Peter L Collins
Journal:  Expert Rev Respir Med       Date:  2011-08       Impact factor: 3.772

7.  Evaluation of a clinical scoring system and directed laboratory testing for respiratory virus infection in hematopoietic stem cell transplant recipients.

Authors:  P E Ferguson; N M Gilroy; T P Sloots; M D Nissen; D E Dwyer; T C Sorrell
Journal:  Transpl Infect Dis       Date:  2011-04-18       Impact factor: 2.228

8.  Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study.

Authors:  Antonio Piralla; Elena Percivalle; Alessandra Di Cesare-Merlone; Franco Locatelli; Giuseppe Gerna
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

9.  Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany.

Authors:  Steffen Geis; Christiane Prifert; Benedikt Weissbrich; Nicola Lehners; Gerlinde Egerer; Christoph Eisenbach; Udo Buchholz; Elisabeth Aichinger; Peter Dreger; Kai Neben; Ulrich Burkhardt; Anthony D Ho; Hans-Georg Kräusslich; Klaus Heeg; Paul Schnitzler
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

10.  Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes.

Authors:  S Seo; H Xie; R A Karron; B Thumar; J A Englund; W M Leisenring; T Stevens-Ayers; M Boeckh; A P Campbell
Journal:  Bone Marrow Transplant       Date:  2014-06-30       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.